Literature DB >> 26137115

Experimental research of Fuaile medical adhesive for portal vein embolization in white rabbit models.

Tianpeng Jiang1, Lizhou Wang1, Xing Li1, Jie Song1, Xiaoping Wu1, Tianzhi An1, Shi Zhou1.   

Abstract

The aim of the present study was to investigate the feasibility and efficacy of Fuaile medical adhesive for portal vein embolization in the treatment of a rabbit model. This study used 26 white rabbits, 14 of which were selected and assigned into seven groups (n=2) for the preliminary experiment. Fuaile medical adhesive was mixed with lipiodol at different ratios of 1:0, 1:1, 1:2, 1:3, 1:4, 1:5 and 0:1, respectively, and administered via the portal trunk. The remaining 12 white rabbits were randomly divided into two groups (n=6). The evaluation of the results included the degree of adhesion to the vessels, the extent of embolization and the reaction of the rabbit. Hepatic and renal functions were detected prior to and at 1, 7 and 14 days post-embolization, respectively. Angiography, CT scans and pathological examinations were conducted at post-embolization. Histological examinations revealed that the topical swollen lesions were darker. Light microscopy showed embolic agents in the portal venous blood vessels and the formation of a secondary thrombus. Hepatic necrosis appeared surrounding the embolization area. Inflammatory cell infiltration of different degrees occurred in the early stage and inflammatory fibroplasia occurred in the late stage. Alanine aminotransferase and aspartate aminotransferase levels increased at 1 day post-embolization, peaked at 7 days and was in the normal range at 14 days. The levels of blood urea nitrogen and ceruloplasmin were elevated at 1 day post-embolization and lowered to normal at 7 days. Fuaile medical adhesive is an effective, safe and inexpensive agent, used for effectively inducing embolization in the portal trunk, and the first and second branches of rabbit portal veins. The use of Fuaile therefore merits widespread application in clinical practice.

Entities:  

Keywords:  Fuaile medical adhesive; portal vein embolization

Year:  2015        PMID: 26137115      PMCID: PMC4473367          DOI: 10.3892/ol.2015.3142

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  8 in total

1.  Combination of preoperative embolization of the right portal vein and hepatic artery prior to major hepatectomy in high-risk patients: a preliminary report.

Authors:  S Inaba; T Takada; H Amano; M Yoshida; Y Yamakawa; H Yasuda; Y Takada; K Takeshita; H Koutake; K Takada; S Furui; H Hijikata; K Takada
Journal:  Hepatogastroenterology       Date:  2000 Jul-Aug

2.  Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function.

Authors:  H Tanaka; K Hirohashi; S Kubo; T Shuto; I Higaki; H Kinoshita
Journal:  Br J Surg       Date:  2000-07       Impact factor: 6.939

3.  Combined transcatheter arterial chemoembolization and beta-ultrasound guided portal vein embolization in the treatment of hepatocellular carcinoma.

Authors:  Guoxin Mao; Zhijian Yu; Yixin Zhang; Jianping Cheng
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2002-07

4.  Nonadhesive liquid embolic agent: role of its components in histologic changes in embolized arteries.

Authors:  A Sadato; Y Numaguchi; W Taki; H Iwata; K Yamshita
Journal:  Acad Radiol       Date:  1998-03       Impact factor: 3.173

5.  Preoperative portal vein embolization for major liver resection: a meta-analysis.

Authors:  Adel Abulkhir; Paolo Limongelli; Andrew J Healey; Osama Damrah; Paul Tait; James Jackson; Nagy Habib; Long R Jiao
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

6.  Skull-base tumors: ethanol embolization of the cavernous carotid artery.

Authors:  C A Jungreis
Journal:  Radiology       Date:  1991-12       Impact factor: 11.105

7.  Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma.

Authors:  Koji Kamada; Mikiya Kitamoto; Hiroshi Aikata; Yoshiiku Kawakami; Hirotaka Kono; Michio Imamura; Toshio Nakanishi; Kazuaki Chayama
Journal:  Am J Surg       Date:  2002-09       Impact factor: 2.565

8.  Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.

Authors:  C Bartolozzi; R Lencioni; D Caramella; C Vignali; R Cioni; S Mazzeo; M Carrai; G Maltinti; A Capria; P F Conte
Journal:  Radiology       Date:  1995-12       Impact factor: 11.105

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.